Translational Medicine R&D Center, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, PR China.
Translational Medicine R&D Center, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, PR China; Shenzhen Bioactive Materials Engineering Lab for Medicine, Shenzhen 518055, PR China.
Biomaterials. 2018 Jan;153:1-13. doi: 10.1016/j.biomaterials.2017.10.025. Epub 2017 Oct 23.
Steroid-associated osteonecrosis (SAON) often requires surgical core decompression (CD) in the early stage for removal of necrotic bone to facilitate repair where bone grafts are needed for filling bone defect and avoiding subsequent joint collapse. In this study, we developed a bioactive composite scaffold incorporated with icariin, a unique phytomolecule that can provide structural and mechanical support and facilitate bone regeneration to fill into bone defects after surgical CD in established SAON rabbit model. An innovative low-temperature 3D printing technology was used to fabricate the poly (lactic-co-glycolic acid)/β-calcium phosphate/icariin (PLGA/TCP/Icariin, PTI) scaffold. The cytocompatibility of the PTI scaffold was tested in vitro, and the osteogenesis properties of PTI scaffolds were assessed in vivo in the SAON rabbit models. Our results showed that the fabricated PTI scaffold had a well-designed biomimic structure that was precisely printed to provide increased mechanical support and stable icariin release from the scaffold for bone regeneration. Furthermore, our in vivo study indicated that the PTI scaffold could enhanced the mechanical properties of new bone tissues and improved angiogenesis within the implanted region in SAON rabbit model than those of PLGA/TCP (PT) scaffold. The underlying osteoblastic mechanism was investigated using MC3T3-E1 cells in vitro and revealed that icariin could facilitate MC3T3-E1 cells ingrowth into the PTI scaffold and regulate osteoblastic differentiation. The PTI scaffold exhibited superior biodegradability, biocompatibility, and osteogenic capability compared with those of PT scaffold. In summary, the PTI composite scaffold which incorporated bioactive phyto-compounds is a promising potential strategy for bone tissue engineering and regeneration in patients with challenging SAON.
类固醇相关骨坏死(SAON)常需要在早期进行外科核心减压(CD)以去除坏死骨,以促进修复,必要时需要植骨以填补骨缺损并避免随后的关节塌陷。在这项研究中,我们开发了一种含有淫羊藿素的生物活性复合支架,淫羊藿素是一种独特的植物分子,可为结构和机械支撑提供支持,并促进骨再生,以填充在已建立的 SAON 兔模型中的外科 CD 后骨缺损。采用创新的低温 3D 打印技术制造聚(乳酸-共-乙醇酸)/β-磷酸三钙/淫羊藿素(PLGA/TCP/Icariin,PTI)支架。在体外测试了 PTI 支架的细胞相容性,并在 SAON 兔模型中体内评估了 PTI 支架的成骨性能。我们的结果表明,所制造的 PTI 支架具有精心设计的仿生结构,可以精确打印,从而为骨再生提供更高的机械支撑和稳定的支架中淫羊藿素的释放。此外,我们的体内研究表明,与 PLGA/TCP(PT)支架相比,PTI 支架可以增强新骨组织的机械性能并改善植入区域内的血管生成。在体外使用 MC3T3-E1 细胞进行了潜在的成骨机制研究,结果表明淫羊藿素可以促进 MC3T3-E1 细胞长入 PTI 支架并调节成骨细胞分化。与 PT 支架相比,PTI 支架表现出更好的生物降解性、生物相容性和成骨能力。总之,该支架将生物活性植物化合物与支架相结合,是治疗类固醇相关骨坏死的一种有前途的策略。